Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.195 EUR
−28.34 M EUR
−3.62 M EUR
20.19 M
About VIVORYON THERAPEUTICS N.V.
Sector
Industry
CEO
Frank T. Weber
Website
Headquarters
Halle
Founded
2001
ISIN
NL00150002Q7
FIGI
BBG0079ZD8K3
Vivoryon Therapeutics NV is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its product pipeline includes PQ912, PBD-C06, and PQ1565. The company was founded by Hans-Ulrich Demuth and Konrad Glund on July 25, 1997 and is headquartered in Halle, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VVY is 2.025 EUR — it hasn't changed in the past 24 hours. Watch VIVORYON THERAPEUTICS N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange VIVORYON THERAPEUTICS N.V. stocks are traded under the ticker VVY.
VVY stock has fallen by −0.98% compared to the previous week, the month change is a −13.98% fall, over the last year VIVORYON THERAPEUTICS N.V. has showed a −74.43% decrease.
We've gathered analysts' opinions on VIVORYON THERAPEUTICS N.V. future price: according to them, VVY price has a max estimate of 7.20 EUR and a min estimate of 2.50 EUR. Watch VVY chart and read a more detailed VIVORYON THERAPEUTICS N.V. stock forecast: see what analysts think of VIVORYON THERAPEUTICS N.V. and suggest that you do with its stocks.
VVY stock is 2.01% volatile and has beta coefficient of 2.76. Track VIVORYON THERAPEUTICS N.V. stock price on the chart and check out the list of the most volatile stocks — is VIVORYON THERAPEUTICS N.V. there?
Today VIVORYON THERAPEUTICS N.V. has the market capitalization of 52.92 M, it has decreased by −0.98% over the last week.
Yes, you can track VIVORYON THERAPEUTICS N.V. financials in yearly and quarterly reports right on TradingView.
VIVORYON THERAPEUTICS N.V. is going to release the next earnings report on Apr 24, 2025. Keep track of upcoming events with our Earnings Calendar.
VVY net income for the last half-year is −13.56 M EUR, while the previous report showed −17.63 M EUR of net income which accounts for 23.07% change. Track more VIVORYON THERAPEUTICS N.V. financial stats to get the full picture.
No, VVY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 17.00 employees. See our rating of the largest employees — is VIVORYON THERAPEUTICS N.V. on this list?
Like other stocks, VVY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIVORYON THERAPEUTICS N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VIVORYON THERAPEUTICS N.V. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VIVORYON THERAPEUTICS N.V. stock shows the strong sell signal. See more of VIVORYON THERAPEUTICS N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.